Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Extension of previous funding round brings total raised to £7 million GBP (circa $9.2 million USD) Investment from Calculus Capital, Par Equity, and Scottish Enterprise Funding will
PENTICTON, BC / ACCESSWIRE / April 6, 2022 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), announced that it has filed its Quarterly Financials and MD&A under its profile on SEDAR with
InFlectis BioScience granted Orphan Drug Designation for IFB-088 (icerguastat), a clinical stage treatment for Amyotrophic Lateral Sclerosis
PENTICTON, BC / ACCESSWIRE / March 23, 2022 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), reports that, pursuant to the Board of Directors Ancillary Compensation Agreement (the "Compensation
Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization coverage and reducing vaccine wastage